Actelion Executive To Head American College of Cardiology

Shalom “Shal” Jacobovitz will be the new chief executive officer of the American College of Cardiology, the ACC announced today. Jacobovitz is currently the president of the US division of Actelion Pharmaceuticals, best known for its pulmonary hypertension drugs.

Click here to read the complete story on Forbes.

Shalom Jacobovitz

 

Leave a Reply

%d bloggers like this: